eli lilly retatrutide trials Lilly's tirzepatide showed positive results in late-stage trial as treatment for heart failure ESC 2024: Retatrutide improves lipid

LY3437943 Molecular Formula C 221 H 342 N 46 O 68 Molecular Weight 4731.34 g/mol Sequence 39-amino acid synthetic peptide with C20 fatty diacid modification Physical Form White to off-white lyophilized powder Storage Store at -20C before reconstitution

Current Availability and Regulatory Status in the UK Retatrutide is not approved for clinical use in the UK as of April 2025 and can only be accessed through MHRA-registered clinical trials

Skin sensitivity is believed to be related to the glucagon receptor component

Almutairi, M

Testosterone stores at room temperature away from direct light

These patents were originally filed as an international application on March 20, 2006